Sunshine Biopharma Inc. Debt Conversion, Converted Instrument, Amount
Sunshine Biopharma Inc. (SBFM) reported Debt Conversion, Converted Instrument, Amount of $190.49 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2019-11-13
- Sunshine Biopharma Inc. debt conversion, converted instrument, amount for the quarter ending 2019-09-30 was $125.40K, a 78.79% decline year-over-year.
- Sunshine Biopharma Inc. debt conversion, converted instrument, amount for the quarter ending 2019-06-30 was $42.79K, a 22.55% decline year-over-year.
- Sunshine Biopharma Inc. debt conversion, converted instrument, amount for the quarter ending 2019-03-31 was $22.31K, a 41.82% decline year-over-year.
- Sunshine Biopharma Inc. debt conversion, converted instrument, amount for the quarter ending 2018-09-30 was $591.27K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 3 month as first filed | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 6 month as first filed | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 9 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $125.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $168.19K derived: sum of 2 quarters · filed 2019-11-13 | $190.49K 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | $42.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $65.09K 10-Q · filed 2019-08-15 | ||||
| 2019-03-31 | $22.31K 10-Q · filed 2019-05-20 | |||||
| 2018-09-30 | $591.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $646.51K derived: sum of 2 quarters · filed 2019-11-13 | $684.85K 10-Q · filed 2019-11-13 | $685.10K 10-Q · filed 2018-11-16 | ||
| 2018-06-30 | $55.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $93.58K 10-Q · filed 2019-08-15 | ||||
| 2018-03-31 | $38.34K 10-Q · filed 2019-05-20 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $0.00 derived: sum of 2 quarters · filed 2018-11-16 | $76.93K 10-Q · filed 2018-11-16 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | $76.93K 10-Q · filed 2018-08-17 | ||||
| 2017-03-31 | $76.93K 10-Q · filed 2018-05-22 | |||||
| 2016-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15 | $1.47M derived: sum of 2 quarters · filed 2017-11-15 | $1.72M 10-Q · filed 2017-11-15 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $253.66K 10-Q · filed 2017-08-11 | -$253.66K 10-Q · filed 2016-08-16 | |||
| 2016-03-31 | $253.66K 10-Q · filed 2017-05-12 | -$253.66K 10-Q · filed 2016-05-09 | ||||
| 2015-09-30 | $648.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $359.68K derived: sum of 2 quarters · filed 2016-11-14 | $359.68K 10-Q · filed 2016-11-14 | -$359.68K 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | -$288.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | -$288.93K 10-Q · filed 2016-08-16 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |